-
Hideyuki Hasebe, Kentaro Yoshida, Akihiko Nogami, Yoshitaka Furuyashik ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0769
Published: June 01, 2023
Advance online publication: June 01, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: An epicardial connection (EC) between the right-sided pulmonary venous (RtPV) carina and right atrium (RA) may preclude PV isolation, but its electrophysiological role during atrial fibrillation (AF) remains unknown.
Methods and Results: This prospective observational study included 98 consecutive patients undergoing catheter ablation for AF, subdivided into the EC group (n=17) and non-EC group (n=80) based on observation of RA posterior wall breakthrough during RtPV pacing. Mean left atrial (LA) dominant frequency (mean DFLA) was defined as the averaged DFs at the right and left PVs and LA appendage. The regional DF was higher in the EC group vs. the non-EC group except at the left PV antrum. The DF at the RA appendage (RAA) and mean DFLAwere equivocal (6.5±0.7 vs. 6.6±0.7 Hz) in the EC group, but the mean DFLAwas significantly higher than that at the RAA (5.8±0.6 vs. 6.1±0.5 Hz, P=0.001) in the non-EC group, suggesting an LA-to-RA DF gradient. A significant correlation of DF between the RtPV antrum and RAA was observed in the EC group (P<0.001, r=0.84) but not in the non-EC group.
Conclusions: An electrophysiological link via interatrial ECs might attenuate the hierarchical nature of activation frequencies of AF, leading to advanced electrical remodeling of the atria.
View full abstract
-
Kazuoki Dai, Nobuo Shiode, Kanade Yoshii, Yuka Kimura, Keita Matsuo, Y ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0221
Published: June 01, 2023
Advance online publication: June 01, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Lipoprotein (a) (Lp(a)) is a complex circulating lipoprotein, and there is increasing evidence it is a risk factor for atherosclerotic cardiovascular disease (ASCVD). This study aimed to investigate the influence of Lp(a) serum levels on long-term outcomes after acute myocardial infarction (AMI).
Methods and Results: Between January 2015 and January 2018, we enrolled 262 patients with AMI who underwent coronary angiography within 24 h of the onset of chest pain and had available Lp(a) data enabling subdivision into 2 groups: high Lp(a) (≥32 mg/dL: n=76) and low Lp(a) (<32 mg/dL: n=186). The primary endpoint was major adverse cardiac events (MACE), which was defined as a composite of cardiac death, nonfatal MI, and readmission for heart failure. Multivariate Cox regression analysis was performed to identify the predictors of MACE. The incidence of MACE was significantly higher in the high Lp(a) group than in the low Lp(a) group (32.8% vs. 19.6%, P=0.004). Multivariate analysis showed that Lp(a) ≥32 mg/dL was an independent predictor of MACE (hazard ratio 2.84, 95% confidence interval 1.25–6.60, P=0.013).
Conclusions: High Lp(a) levels were associated with worse long-term outcomes after AMI, so Lp(a) may be useful for risk assessment.
View full abstract
-
Teruhiko Imamura, Koichiro Kinugawa, Takashi Nishimura, Koichi Toda, Y ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0264
Published: June 01, 2023
Advance online publication: June 01, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Recently, destination therapy (DT) was approved in Japan, and patients ineligible for heart transplantation may now receive durable left ventricular assist devices (LVADs). Several conventional risk scores are available, but a risk score that is best to select optimal candidates for DT in the Japanese population remains unestablished.
Methods and Results: A total of 1,287 patients who underwent durable LVAD implantation and were listed for the Japanese registry for Mechanically Assisted Circulatory Support (J-MACS) were eligible for inclusion. Finally, 494 patients were assigned to the derivation cohort and 487 patients were assigned to the validation cohort. According to the time-to-event analyses, J-MACS risk scores were newly constructed to predict 3-year mortality rate, consisting of age, history of cardiac surgery, serum creatinine level, and central venous pressure to pulmonary artery wedge pressure ratio >0.71. The J-MACS risk score had the highest predictability of 3-year death compared with other conventional scores in the validation cohort, including HeartMate II risk score and HeartMate 3 risk score.
Conclusions: We constructed the J-MACS risk score to estimate 3-year mortality rate after durable LVAD implantation using large-scale multicenter Japanese data. The clinical utility of this scoring to guide the indication of DT should be validated in the next study.
View full abstract
-
Michifumi Tokuda, Seigo Yamashita, Satoko Shiomi, Ryutaro Sakurai, Hid ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0048
Published: May 30, 2023
Advance online publication: May 30, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Pulmonary vein stenosis (PVS) after PV isolation (PVI) for atrial fibrillation (AF) is a severe complication that requires angioplasty. This study aimed to compare the reduction of the cross-sectional PV area (PVA) and the incidence of PVS after cryoballoon (CB)-PVI, hot balloon (HB)-PVI, or laser balloon (LB)-PVI.
Methods and Results: A total of 320 patients who underwent an initial catheter ablation procedure for AF using a CB, HB, or LB in 2 hospitals were included. They underwent contrast-enhanced multidetector CT before and 3 months after the procedure. In all 4 PVs, the reduction in PVA was more significant in the LB group than in the CB or HB groups, respectively. Moderate (50–75%) and severe (>75%) PVS were observed in 5.3% and 0.5% of the PVs, respectively. Although moderate PVS was more frequently observed in the LB group than in the CB or HB groups (8.2%, 3.8%, and 5.0%; P=0.03), the incidence of severe PVS was similar in the LB, CB, and HB groups (0.3%, 0.5%, and 1.0%; P=0.46). Symptomatic PVS requiring intervention occurred in 1 (0.3%) patient.
Conclusions: Although the reduction in cross-sectional PVA and the incidence of moderate PVS after LB-PVI was more significant than after CB-PVI or HB-PVI, it rarely led to severe PVS. Symptomatic PVS requiring intervention was rare after the balloon ablation of AF.
View full abstract
-
Ji Woong Roh, SungA Bae, Thomas W. Johnson, Seok-Jae Heo, Yongcheol Ki ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0189
Published: May 30, 2023
Advance online publication: May 30, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: In the setting of acute myocardial infarction (AMI), there are no data regarding the benefits of intravascular ultrasound (IVUS) for chronic kidney disease (CKD) patients.
Methods and Results: This study used data from the Korea Acute Myocardial Infarction Registry, a large, multicenter prospective cohort. We evaluated 1,759 patients with AMI and CKD, defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2, and patients were classified into 2 groups: with and without IVUS. The primary outcome was target lesion failure (TLF) at 3 years. The hazard ratio (HR) of TLF according to eGFR was also analyzed. A total of 1,759 patients with AMI and CKD who underwent IVUS-guided PCI (19.2%) had a significantly lower risk of TLF at 3 years (8.9% vs. 15.3%; HR 0.55; 95% confidence interval [CI]: 0.38 to 0.81; P=0.002) than those who underwent angiography-guided PCI, regardless of their eGFR and the presence of end-stage renal disease (ESRD). The results were consistent after confounder adjustment and inversed probability weighting.
Conclusions: In patients with CKD and AMI who underwent PCI with 2nd-generation DES implantation, the use of IVUS guidance was associated with a significant reduction in 3-year TLF and showed consistently favorable outcomes regardless of eGFR and ESRD.
View full abstract
-
Ikuo Fukuda, Atsushi Hirayama, Kazuo Kawasugi, Takao Kobayashi, Hideak ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0104
Published: May 27, 2023
Advance online publication: May 27, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: The incidence of venous thromboembolism (VTE; pulmonary embolism [PE] and/or deep vein thrombosis [DVT]) in Japan is increasing, but relatively small numbers of patients from Japan have been included in studies investigating rivaroxaban (a direct factor Xa inhibitor) for the treatment of VTE and preventing its recurrence.
Methods and Results: An open-label, prospective, observational study (XASSENT [NCT02558465]) investigated the safety profile and effectiveness of rivaroxaban for ≤2 years in the treatment of VTE and prevention of its recurrence in Japanese clinical practice. Primary outcomes were major bleeding and symptomatic recurrent VTE. Statistical analyses were exploratory and descriptive. Overall, 2,540 patients were enrolled (safety analysis population [SAP], n=2,387; effectiveness analysis population [EAP], n=2,386). In the SAP, >80% of patients received the approved rivaroxaban dose, the mean (standard deviation) age was 66.6 (15.0) years, ≈74% were >50 kg, and 43% had a creatinine clearance ≥80 mL/min. PE+DVT, PE only, and DVT only were reported in 42%, 8%, and 50% of patients, respectively, and active cancer in 17% of patients. Major bleeding was reported in 69 patients (2.89%; 3.60%/patient-year; SAP) and symptomatic PE/DVT recurrence in 26 patients (1.09%; 1.36%/patient-year; EAP) during the treatment period.
Conclusions: XASSENT provided information on the expected proportions of bleeding and VTE recurrence during rivaroxaban treatment in Japanese clinical practice; no new concerns of safety or effectiveness were found.
View full abstract
-
Shusuke Yagi, Tomoya Hara, Hirotsugu Yamada, Kenya Kusunose, Takayuki ...
Article type: IMAGES IN CARDIOVASCULAR MEDICINE
Article ID: CJ-23-0029
Published: May 26, 2023
Advance online publication: May 26, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
-
Tomohiko Taniguchi, Yuhei Hasegawa, Kitae Kim, Natsuhiko Ehara, Yutaka ...
Article type: IMAGES IN CARDIOVASCULAR MEDICINE
Article ID: CJ-23-0205
Published: May 24, 2023
Advance online publication: May 24, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
-
Yugo Yamashita
Article type: EDITORIAL
Article ID: CJ-23-0291
Published: May 24, 2023
Advance online publication: May 24, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Xiafeng Peng, Shixin Wang, Jing Wang, Weizhu Ju, Gang Yang, Kai Gu, Ha ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0694
Published: May 23, 2023
Advance online publication: May 23, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Previous studies revealed a relationship between 8-hydroxy-2′-deoxyguanosine (8-OHdG) and the occurrence/recurrence of atrial fibrillation (AF). This 2-part study aimed to validate whether DNA damage related to 8-OHdG is associated with left atrial (LA) fibrosis in AF patients quantified by voltage mapping (Part I), and to identify the underlying genetic components regulating the 8-OHdG level (Part II).
Methods and Results: Plasma 8-OHdG determination, DNA extraction, and genotyping were conducted before catheter ablation. LA voltage mapping was performed under sinus rhythm. According to the percentage of low voltage area (LVA), patients were categorized as stage I (<5%), stage II (5–10%), stage III (10–20%), and stage IV (>20%). Part I included 209 AF patients. The 8-OHdG level showed an upward trend together with advanced LVA stage (stage I 8.1 [6.1, 10.5] ng/mL, stage II 8.5 [5.7, 14.1] ng/mL, stage III 14.3 [12.1, 16.5] ng/mL, stage IV 13.9 [10.5, 16.0] ng/mL, P<0.000). Part II included 175 of the 209 patients from Part I. Gene-set analysis based on genome-wide association study summary data identified that the gene set named ‘DNA methylation on cytosine’ was the only genetic component significantly associated with 8-OHdG concentration.
Conclusions: Higher 8-OHdG levels may predict more advanced LVA of the LA in AF patients. DNA methylation is the putative genetic component underlying oxidative DNA damage in AF patients.
View full abstract
-
Akio Chikata, Takeshi Kato, Kazuo Usuda, Masayuki Takamura
Article type: IMAGES IN CARDIOVASCULAR MEDICINE
Article ID: CJ-23-0233
Published: May 23, 2023
Advance online publication: May 23, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Yosuke Higo, Yuichi Sawayama, Naoyuki Takashima, Akiko Harada, Yuichir ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0758
Published: May 20, 2023
Advance online publication: May 20, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Acute aortic dissection (AAD) is a life-threatening cardiovascular disease, with a reported incidence rate ranging from 2.5 to 7.2 per 100,000 person-years in several population-based registries in Western countries, but epidemiological data are lacking in Japan.
Methods and Results: The Shiga Stroke and Heart Attack Registry is an ongoing multicenter population-based registry of cerebro-cardiovascular diseases. We enrolled patients who developed AAD, defined by any imaging examination method from 2014 to 2015 in Shiga Prefecture. Death certificates were used to identify cases that were not registered at acute care hospitals. The incidence rates of AAD were calculated by age categories and adjusted using standard populations for comparison. We evaluated differences in patient characteristics between Stanford type A-AAD and type B-AAD subtypes. A total of 402 incident cases with AAD were analyzed. The age-adjusted incidence rates using the 2015 Japanese population and the 2013 European Standard Population were 15.8 and 12.2 per 100,000 person-years, respectively. Compared with cases of type B-AAD, those with type A-AAD were older (75.0 vs. 69.9 years, P=0.001) and more likely to be women (62.3% vs. 28.6%, P<0.001).
Conclusions: Population-based incidence rates of AAD in Japan appear to be higher than in previous reports from Western countries. Incident cases with type A-AAD were older and female predominance.
View full abstract
-
Kenji Yokoyama, Tomoya Yoshizaki, Eiki Nagaoka, Dai Tasaki, Hirokuni A ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0764
Published: May 18, 2023
Advance online publication: May 18, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Grafting the right gastroepiploic artery (GEA) to the right coronary artery (RCA) is effective, but preoperative evaluation of arterial conduit availability has not been established. By comparing the midterm graft results, we aimed to assess the efficacy of preoperative evaluation of the GEA using computed tomography (CT).
Methods and Results: We retrospectively examined patients who underwent isolated coronary artery bypass grafting surgery between April 2010 and December 2020, and those whose GEA was grafted to the RCA were selected: 55 patients were included in the study analysis. Postoperative evaluations were performed during the early phase, 1 year postoperatively, and at follow-up evaluations. The outer diameter of the proximal GEA was compared with the midterm graft patency grade on CT and patients were classified as Functional (Grade A) or Dysfunctional (Grades O or B). The proximal GEA outer diameters were significantly different between the Functional and Dysfunctional groups (P<0.001). Furthermore, multivariate Cox regression analysis revealed that this diameter was an independent predictor of graft functionality (P<0.001). Patients with outer proximal diameters larger than the cutoff value had superior graft results at 3 years postoperatively. The rate of freedom from a dysfunctional graft at 3 years postoperatively was 95.5% and 45.5% for the Larger and Smaller diameter subgroups, respectively (P<0.001).
Conclusions: Preoperative evaluation of the outer diameter of the proximal GEA, excluding calcified GEA, using CT is a minimally invasive and useful method, and may improve midterm results of in-situ GEA grafting, even in severe stenotic lesions.
View full abstract
-
Taishi Miyata, Hiroyuki Yamamoto, Tomofumi Takaya
Article type: IMAGES IN CARDIOVASCULAR MEDICINE
Article ID: CJ-23-0149
Published: May 17, 2023
Advance online publication: May 17, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
-
Shintaro Togashi, Tsuyoshi Isawa, Taku Honda, Kenichi Furuya, Kazuhiro ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0103
Published: May 16, 2023
Advance online publication: May 16, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Because the penetration of transvenous lead extraction (TLE) for cardiac implantable electronic device (CIED) infection has not been investigated in Japan, we conducted a population-based, retrospective, descriptive study to evaluate regional disparities in the use of TLE for CIED infection and the potential undertreatment of CIED infection using a nationwide insurance claims database.
Methods and Results: Patients who underwent CIED implantation or generator exchange and TLE between April 2018 and March 2020 were identified. Moreover, the penetration ratio of TLE for CIED infection in each prefecture was estimated. CIED implantation and TLE were most prevalent in the age categories of 80–89 years (40.3%) and 80–89 years (36.9%), respectively. There was no correlation between the number of CIED implantations and that of TLE (rho=−0.087, 95% confidence interval −0.374 to 0.211, P=0.56). The median penetration ratio was 0.00 (interquartile range 0.00–1.29). Of the 47 prefectures, 6, comprising Okinawa, Miyagi, Okayama, Fukuoka, Tokyo, and Osaka, showed a penetration ratio ≥2.00.
Conclusions: Our study data indicated great regional disparities in the penetration of TLE and potential undertreatment of CIED infection in Japan. Additional measures are needed to address these issues.
View full abstract
-
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Akiyoshi Miyazawa, Hirok ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0141
Published: May 16, 2023
Advance online publication: May 16, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: There is a scarcity of data evaluating contemporary real-world dual antiplatelet therapy (DAPT) strategies after percutaneous coronary intervention (PCI).
Methods and Results: In the OPTIVUS-Complex PCI study multivessel cohort enrolling 982 patients undergoing multivessel PCI, including left anterior descending coronary artery using intravascular ultrasound (IVUS), we conducted 90-day landmark analyses to compare shorter and longer DAPT. DAPT discontinuation was defined as withdrawal of P2Y12inhibitors or aspirin for at least 2 months. The prevalence of acute coronary syndrome and high bleeding risk by the Bleeding Academic Research Consortium were 14.2% and 52.5%, respectively. The cumulative incidence of DAPT discontinuation was 22.6% at 90 days, and 68.8% at 1 year. In the 90-day landmark analyses, there were no differences in the incidences of a composite of death, myocardial infarction, stroke, or any coronary revascularization (5.9% vs. 9.2%, log-rank P=0.12; adjusted hazard ratio, 0.59; 95% confidence interval, 0.32–1.08; P=0.09) and BARC type 3 or 5 bleeding (1.4% vs. 1.9%, log-rank P=0.62) between the off- and on-DAPT groups at 90 days.
Conclusions: The adoption of short DAPT duration was still low in this trial conducted after the release of the STOPDAPT-2 trial results. The 1-year incidence of cardiovascular events was not different between the shorter and longer DAPT groups, suggesting no apparent benefit of prolonged DAPT in reducing cardiovascular events even in patients who undergo multivessel PCI.
View full abstract
-
Mitsuyasu Terashima, Hideaki Kaneda
Article type: EDITORIAL
Article ID: CJ-23-0245
Published: May 16, 2023
Advance online publication: May 16, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Shigeki Kimura, Ami Isshiki, Masato Shimizu, Hiroyuki Fujii, Makoto Su ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0031
Published: May 12, 2023
Advance online publication: May 12, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Coronary healed plaques (HPs) reportedly have high vulnerability or show advanced atherosclerosis and a risk of rapid plaque progression. However, the prognosis of stable angina pectoris (SAP) patients with HPs undergoing percutaneous coronary intervention (PCI) remains under-investigated.
Methods and Results: We analyzed 417 consecutive lesions from SAP patients undergoing pre- and post-intervention optical coherence tomography (OCT) for which HPs were defined as having a layered appearance. We investigated the differences in clinical and lesion characteristics, and post-PCI outcomes between HPs and non-HPs. To account for differences in clinical characteristics, propensity score matching was performed between the groups. HPs were observed in 216 lesions (51.8%) in the total cohort. In the propensity-matched cohort (n=294), HPs had higher rates of angiographic-B2/C lesions (77.6% vs. 59.2%, P<0.001), OCT-lipid-rich plaques (40.8% vs. 25.9%, P=0.007), macrophages (78.2% vs. 44.2%, P<0.001), greater luminal area stenosis (73.5±11.0% vs. 71.5±10.3%, P=0.002), and a higher prevalence of post-stenting irregular tissue protrusion (45.1% vs. 14.7%, P<0.001) than non-HPs. In the total cohort, target lesion revascularization (TLR)-free survival was poorer for HPs (log-rank test 7.66; P=0.006), and Cox proportional hazards analysis showed HP as an independent predictor of TLR (hazard ratio, 5.98; 95% confidence interval, 1.72–20.82; P=0.005).
Conclusions: In SAP patients, HPs had greater complexity of lesions and higher vulnerability, which may have contributed to the poorer post-PCI outcomes.
View full abstract
-
Yusuke Sato, Tetsuji Morishita, Yuya Matsunaka, Tomohiro Shimizu, Hiro ...
Article type: IMAGES IN CARDIOVASCULAR MEDICINE
Article ID: CJ-23-0173
Published: May 09, 2023
Advance online publication: May 09, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
-
Kentaro Hori, Atsuko Nakayama, Daichi Kobayashi, Yuichi Adachi, Kotaro ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0102
Published: May 02, 2023
Advance online publication: May 02, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: We investigated the components of frailty associated with hospitalization-associated disability (HAD) after cardiac surgery.
Methods and Results: This retrospective, observational study evaluated 1,446 older patients after elective cardiac surgery at the Sakakibara Heart Institute. We examined the association between HAD and 7 domains of frailty assessed by the Kihon Checklist. HAD was defined as a decline in the ability to perform activities of daily living (ADL) between admission and discharge, as assessed by the Barthel Index. Logistic regression and decision tree analysis were used to identify associations between the number and type of frailty components and HAD. Of the 1,446 patients, 190 were excluded, and 90 (7%) developed HAD. An increase in the number of frailty components was a risk factor for HAD (odds ratio: 1.88, 95% confidence interval: 1.62–2.17). Decision tree analysis identified physical functional decline, depression, and cognitive dysfunction as factors associated with HAD. The incidence of HAD was highest in cases of physical functional decline (21%) and lowest for cases in which the 3 aforementioned factors were absent (2.8%).
Conclusions: An increased number of frailty factors increased the risk of HAD and the findings also reaffirmed the importance of a comprehensive assessment to evaluate the risk of HAD, including evaluation of physical function, cognitive function, and depression.
View full abstract
-
Yu Sato, Akiomi Yoshihisa, Tomomi Ide, Takeshi Tohyama, Nobuyuki Enzan ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0774
Published: April 28, 2023
Advance online publication: April 28, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: The present study aimed to clarify the regional variations in clinical practice and the prognosis of patients with heart failure with reduced ejection fraction (HFrEF) in Japan using the Japanese Registry of Acute Decompensated Heart Failure (JROADHF).
Methods and Results: We recruited data of hospitalized patients with HFrEF (n=4,329) from the JROADHF. The patients were divided into 6 groups based on the region of Japan where they were hospitalized: Hokkaido-Tohoku (n=504), Kanto (n=958), Chubu (n=779), Kinki (n=902), Chugoku-Shikoku (n=446), and Kyushu (n=740). We compared the patients’ characteristics, including etiology of HF and prognosis after discharge. The age of the patients was lowest in the Kanto and Kinki regions. In contrast, there were no differences in the prevalence of comorbidities, levels of B-type natriuretic peptide, or left ventricular EF among the 6 groups. Post-discharge cardiospecific prognosis, specifically, the composite of cardiac death or HF hospitalization, cardiac death, and HF hospitalization, was comparable among the 6 regions.
Conclusions: There were no differences in cardiospecific prognosis in patients with HFrEF among the 6 regions in Japan.
View full abstract
-
Rongjian Zhan, Jing Zhang, Xuanyu Chen, Tong Liu, Yangsheng He, Shaozh ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0037
Published: April 26, 2023
Advance online publication: April 26, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Hypertensive patients show highly heterogeneous treatment effects (HTEs) and cardiovascular prognosis, and not all benefit from intensive blood pressure treatment.
Methods and Results: We used the causal forest model to identify potential HTEs of patients in the Systolic Blood Pressure Intervention Trial (SPRINT). Cox regression was performed to assess hazard ratios (HRs) for cardiovascular disease (CVD) outcomes and to compare the effects of intensive treatment among groups. The model revealed 3 representative covariates and patients were partitioned into 4 subgroups: Group 1 (baseline body mass index [BMI] ≤28.32 kg/m2and estimated glomerular filtration rate [eGFR] ≤69.53 mL/min/1.73 m2); Group 2 (baseline BMI ≤28.32 kg/m2and eGFR >69.53 mL/min/1.73 m2); Group 3 (baseline BMI >28.32 kg/m2and 10-year CVD risk ≤15.8%); Group 4 (baseline BMI >28.32 kg/m2and 10-year CVD risk >15.8%). Intensive treatment was shown to be beneficial only in Group 2 (HR 0.54, 95% confidence interval [CI] 0.35–0.82; P=0.004) and Group 4 (HR 0.69, 95% CI 0.52–0.91; P=0.009).
Conclusions: Intensive treatment was effective for patients with high BMI and 10-year CVD risk, or low BMI and normal eGFR, but not for those with low BMI and eGFR, or high BMI and low 10-year CVD risk. Our study could facilitate the categorization of hypertensive patients, ensuring individualized therapy.
View full abstract
-
Hideki Ishii
Article type: EDITORIAL
Article ID: CJ-23-0203
Published: April 14, 2023
Advance online publication: April 14, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Taro Takeuchi, Shumpei Kosugi, Yasunori Ueda, Kuniyasu Ikeoka, Haruya ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0838
Published: April 12, 2023
Advance online publication: April 12, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: It remains controversial whether a cancer history increases the risk of cardiovascular (CV) events among patients with myocardial infarction (MI) who undergo revascularization.
Methods and Results: Patients who were confirmed as type 1 acute MI (AMI) by coronary angiography were retrospectively analyzed. Patients who died in hospital or those not undergoing revascularization were excluded. Patients with a cancer history were compared with those without it. A cancer history was examined in the in-hospital cancer registry. The primary outcome was a composite of cardiac death, recurrent type 1 MI, post-discharge coronary revascularization, heart failure hospitalization, and stroke. Among 551 AMI patients, 55 had a cancer history (cancer group) and 496 did not (non-cancer group). Cox proportional hazards model revealed that the risk of composite endpoint was significantly higher in the cancer group than in the non-cancer group (adjusted hazard ratio [HR]: 1.78; 95% confidence interval [CI]: 1.13–2.82). Among the cancer group, patients who were diagnosed as AMI within 6 months after the cancer diagnosis had a higher risk of the composite endpoint than those who were diagnosed as AMI 6 months or later after the cancer diagnosis (adjusted HR: 5.43; 95% CI: 1.55–19.07).
Conclusions: A cancer history increased the risk of CV events after discharge among AMI patients after revascularization.
View full abstract
-
Fumi Yokohama, Yoichi Takaya, Keishi Ichikawa, Rie Nakayama, Takashi M ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0746
Published: April 11, 2023
Advance online publication: April 11, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Patients with severe aortic stenosis (AS) frequently have concomitant aortic regurgitation (AR), but the association between aortic valvular calcification (AVC) and the severity of AR remains unclear.
Methods and Results: We retrospectively reviewed patients with severe AS who underwent transthoracic echocardiography and multidetector computed tomography (MDCT) within 1 month. The patients were divided into 3 groups according to the degree of concomitant AR. The association between AVC and the severity of concomitant AR was assessed in patients with severe AS. The study population consisted of 95 patients: 43 men and 52 women with a mean age of 82±7 years. Of the 95 patients with severe AS, 27 had no or trivial AR, 53 had mild AR, and 15 had moderate AR. The AVC score (AVCS) and AVC volume (AVCV) significantly increased as the severity of concomitant AR increased (P=0.014 for both), and similar findings were obtained for the AVCS and AVCV indexes (P=0.004 for both).
Conclusions: The severity of AR correlated with AVCS and AVCV measured by MDCT in patients with severe AS. AVC may cause concomitant AR, leading to worsening of disease condition.
View full abstract
-
Juanjuan Xue, Peilin Liu, Xiaoshuang Xia, Xuemei Qi, Suqin Han, Lin Wa ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0801
Published: April 08, 2023
Advance online publication: April 08, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Because the effects of extreme weather conditions on stroke severity and outcomes are unclear, we evaluated seasonal variations in stroke severity and clinical outcomes.
Methods and Results: Between 2012 and 2020 we enrolled 5,238 patients with acute ischemic stroke, who were divided into 4 seasons according to stroke onset: spring, summer, autumn and winter. We analyzed the effect of season on the severity and outcomes of all subjects. Multivariable analysis showed that the winter group had 1.234-fold increased risk of moderate-to-severe neurological deficits than the summer group (95% confidence interval (CI): 1.034–1.472, P=0.020). Compared with the summer group, the winter and the spring groups experienced 1.243- and 1.251-fold the risk of suffering from worse outcomes among all patients at 6-month follow-up (95% CI 1.008–1.534, P=0.042, 95% CI 1.013–1.544, P=0.037). The 1-year follow-up revealed similar results. Further comparison of each season in the 2012–2015 and 2016–2020 periods found that the proportion of poor outcomes in the latter autumn group was lower than that in the former time period, with significant differences in both 6-month and 1-year follow-up.
Conclusions: The onset season was related to the severity and clinical outcomes of ischemic stroke. Patients with winter onset had more severe neurological deficits and worse outcomes than those with summer onset.
View full abstract
-
Yi Yen, Kuo-Chun Hung, Yi-Hsin Chan, Victor Chien-Chia Wu, Yu-Ting Che ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0718
Published: April 06, 2023
Advance online publication: April 06, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Studies of the influence of smaller body type on the severity of prosthesis-patient mismatch (PPM) after small-sized surgical aortic valve replacement (SAVR) are few, but the issue is particularly relevant for Asian patients.
Methods and Results: 695 patients who underwent SAVR with bioprosthetic valves had their hemodynamic valve performance analyzed at 3 months, 1 year, 3 years, and 5 years after operation, and clinical outcomes were assessed. The patients were stratified into 3 valve size groups: 19/21, 23, and 25/27 mm. A smaller valve was associated with higher mean pressure gradients at the 4 time points after operation (P trend <0.05). However, the 3 valve size groups demonstrated no significant differences in the risk of clinical events. At none of the time points did patients with projected PPM show increased mean pressure gradients (P>0.05), whereas patients with measured PPM did (P<0.05). Compared with patients with projected PPM, those with measured PPM demonstrated higher rates of infective endocarditis readmission (adjusted hazard ratio [aHR] 3.31, 95% confidence interval [CI] 1.06–10.39) and a higher risk of composite outcomes (aHR 1.45, 95% CI 0.95–2.22, P=0.087).
Conclusions: Relative to those receiving larger valves, patients receiving small bioprosthetic valves had poorer hemodynamic performance but did not demonstrate differences in clinical events in long-term follow-up.
View full abstract
-
Taisuke Nakayama, Yoshitsugu Nakamura, Fumiaki Shikata, Masaki Ushijim ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0587
Published: January 28, 2023
Advance online publication: January 28, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: This study analyzed the safety and performance of the Perceval valve for aortic valve replacement (AVR) in patients at 1 year after undergoing aortic stenosis (AS) treatment, and its effect on significant declines in the platelet count during the immediate postoperative period.
Methods and Results: Data were collected retrospectively for the initial 121 patients (median age 77 years; 47.1% females) who underwent Perceval sutureless AVR between May 2019 and July 2022. Implantation was successful in all (100%), with median cross-clamp and CPB times of 59 and 100 min, respectively. Postoperative thrombocytopenia (platelet count <50×103/μL) was noted in 80 (66.1%) patients. Multivariate analysis showed advanced age (>80 years), preoperative low platelet count (<200×103/μL), and a sternotomy approach as significant risk factors for postoperative thrombocytopenia. One (0.8%) patient died within 30 days after the procedure. The 2-year site-reported event rate was 14% (n=17) for all-cause mortality, 0.8% (n=1) for cardiac mortality, 4.1% (n=5) for stroke, and 1.7% (n=2) for endocarditis and valve-related reoperation; there were no instances of paravalvular leakage or structural valve deterioration.
Conclusions: Thrombocytopenia was common after Perceval sutureless AVR, although its impact was not significant. Although Perceval sutureless AVR was found to be a safe and effective option, preoperative assessment of potential bleeding should be performed and the Perceval valve should not be used for patients with a high bleeding risk.
View full abstract
-
Yuuki Shimizu, Toyoaki Murohara
Article type: EDITORIAL
Article ID: CJ-23-0157
Published: March 31, 2023
Advance online publication: March 31, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Yutaka Iba, Nobuyoshi Kawaharada
Article type: EDITORIAL
Article ID: CJ-23-0130
Published: March 25, 2023
Advance online publication: March 25, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Yoichiro Otaki, Mari Shimizu, Tetsu Watanabe, Shingo Tachibana, Junya ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-23-0088
Published: March 23, 2023
Advance online publication: March 23, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Heart failure (HF) is an increasing health problem associated with a high mortality rate. Growth differentiation factor (GDF) 15, a stress response cytokine belonging to the transforming growth factor-β superfamily, is associated with poor clinical outcomes in a broad spectrum of cardiovascular diseases. However, the prognostic usefulness of GDF15 in Japanese patients with HF remains unclear.
Methods and Results: We measured serum concentrations of GDF15 and B-type natriuretic peptide (BNP) in 1,201 patients with HF. All patients were prospectively followed for a median period of 1,309 days. In all, 319 HF-related events and 187 all-cause deaths occurred during the follow-up period. Kaplan-Meier analysis demonstrated that, among GDF15 tertiles, the highest tertile group had the greatest risk of HF-related events and all-cause mortality. Multivariate Cox proportional hazard regression analysis demonstrated that the serum GDF15 concentration was an independent predictor of HF-related events and all-cause deaths after adjusting for confounding risk factors. Serum GDF15 improved the prediction capacity for all-cause deaths and HF-related events with a significant net reclassification index and integrated discrimination improvement. Subgroup analysis in patients with HF with preserved ejection fraction also showed the prognostic usefulness of GDF15.
Conclusions: Serum GDF15 concentrations were associated with HF severity and clinical outcomes, indicating that GDF15 could provide additional clinical information to track the health status of patients with HF.
View full abstract
-
Tatsuya Mizoguchi, Tomonori Sugiura, Yu Kawada, Junki Yamamoto, Masash ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0772
Published: March 21, 2023
Advance online publication: March 21, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: The number of patients with heart failure (HF) has increased, and it is crucial to prevent the development of HF in patients at risk of HF. The present study aimed to risk stratify patients in Stage A and B HF based on associations between exercise-induced changes in aortic stiffness and exercise tolerance.
Methods and Results: Patients in Stage A and B HF who performed a cardiopulmonary exercise test were enrolled in the study (n=106; median age 65.0 years [interquartile range 52.8–73.0 years]). Exercise tolerance was examined by the percentage of predicted peak oxygen consumption (%V̇O2peak). The ascending aortic pressure waveform was estimated non-invasively. Aortic stiffness was assessed using the augmentation index (AIx) and reflection magnitude (RM). Multivariable regression analysis showed that AIx measured both before and after exercise was significantly associated with %V̇O2peak (β=−0.221 [P=0.049] and β=−0.342 [P=0.003], respectively). When participants were divided into %V̇O2peak subgroups using a cut-off value of 60%, RM decreased immediately after exercise and remained lower 5 min after exercise in the group with preserved exercise tolerance, but recovered to baseline levels 5 min after exercise in the group with reduced exercise tolerance.
Conclusions: Exercise-induced increases in aortic stiffness were associated with exercise tolerance in patients at risk of HF, suggesting that exercise-induced changes in aortic stiffness may be useful to stratify high-risk patients.
View full abstract
-
Isao Saito, Kazumasa Yamagishi, Yoshihiro Kokubo, Hiroshi Yatsuya, Hir ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0805
Published: March 21, 2023
Advance online publication: March 21, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: There is considerable interest in the trending discrepancy between ischemic heart disease (IHD) and heart failure (HF) in vital statistics. Clinically, acute myocardial infarction (AMI) and stroke are closely associated with HF, but their contribution to HF as the underlying cause of death (UCD) is unclear.
Methods and Results: In 1990 and 1992–1993, we enrolled a total of 140,420 residents of Japanese nationality (aged 40–69 years) from 11 public health center areas. We prospectively examined the occurrence of cardiovascular disease (CVD), including AMI, sudden cardiac death within 1 h (SCD), and stroke, and analyzed the 14,375 participants without a history of CVD at baseline who died during the 20-year follow-up. A time-dependent Cox proportional hazards model was used to estimate hazard ratios and the population attributable fraction (PAF) of AMI, AMI+SCD, stroke, and CVD for deaths due to HF, IHD, and cerebrovascular disease as the UCD, adjusted for individuals’ lifestyles and comorbid conditions. The PAF of AMI for HF deaths was 2.4% (95% confidence interval [CI] 1.7–2.9%), which increased to 12.0% (95% CI 11.6–12.2%) for AMI+SCD. The PAF of CVD-attributed HF deaths was estimated to be 17.6% (95% CI 15.9–18.9%).
Conclusions: HF as the UCD was partly explained by CVD. The data imply that most HF deaths reported in vital statistics may be associated with underlying causes other than CVD.
View full abstract
-
Daisuke Endo, Takeshi Kinoshita, Jiyoung Lee, Yoichiro Machida, Kosuke ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0573
Published: March 17, 2023
Advance online publication: March 17, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Patients with end-stage renal disease on hemodialysis (ESRD-HD) have a lifelong risk of atrial fibrillation-related stroke. We compared clinical outcomes in ESRD-HD patients undergoing coronary artery bypass grafting (CABG) with and without concomitant left atrial appendage (LAA) closure.
Methods and Results: Of 2,783 consecutive patients undergoing isolated CABG between 2002 and 2020, 242 patients had ESRD-HD with sinus rhythm. The primary outcome was a composite of death and stroke. An inverse probability (IP)-weighted cohort was created based on the propensity score. The 2 IP-weighted groups had well-balanced baseline and surgical backgrounds, with an equivalent follow-up. Five-year stroke-free survival was significantly higher in patients with LAA closure (log-rank test, P=0.035). The adjusted hazard ratio of LAA closure for death and stroke was 0.43 (95% confidence interval [CI] 0.20–0.92; P=0.023). Competing risk analysis showed that LAA closure was significantly associated with a risk reduction of stroke (subhazard ratio 0.26; 95% CI 0.08–0.96; P=0.028). No significant difference was observed in adjusted risk ratios for reoperation for bleeding, new atrial fibrillation, 30-day mortality, and readmission for heart failure.
Conclusions: Concomitant LAA closure during CABG can reduce the risk of death and stroke in ESRD-HD patients with normal sinus rhythm.
View full abstract
-
Mayumi Kase, Shinya Fujiki, Takeshi Kashimura, Yuji Okura, Kunio Koder ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0830
Published: March 17, 2023
Advance online publication: March 17, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Although guideline-directed medical therapy (GDMT), including β-blockers, angiotensin-converting enzyme inhibitors (ACEi)/angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists (MRAs), improves survival and quality of life, most patients with heart failure with reduced (HFrEF) and mildly reduced (HFmrEF) ejection fraction are treated with inadequate medications. We investigated the prescription patterns of GDMT in elderly patients with HFrEF and HFmrEF and their characteristics, including the certification of long-term care insurance (LTCI), which represents frailty and disability.
Methods and Results: This retrospective cross-sectional study analyzed 1,296 elderly patients with symptomatic HFrEF and HFmrEF with diuretic use (median age 78 years; 63.8% male; median left ventricular ejection fraction 40%). Prescription rates of GDMT were inadequate (ACEi, ARBs, β-blockers, and MRAs: 27.0%, 30.1%, 54.1%, and 41.9%, respectively). LTCI certification was independently associated with reduced prescription of all medications (ACEi/ARB: odds ratio [OR] 0.591, 95% confidence interval [CI] 0.449–0.778, P=0.001; β-blockers: OR 0.698, 95% CI 0.529–0.920, P<0.001; MRAs: OR 0.743, 95% CI 0.560–0.985, P=0.052). Patients with LTCI certification also had a high prevalence of polypharmacy and prescription of diuretics.
Conclusions: Vulnerable patients with LTCI may be an explanation for the challenges in implementing GDMT, and communicating is required for favorable heart failure care in this population.
View full abstract
-
Hirokuni Akahori
Article type: EDITORIAL
Article ID: CJ-23-0090
Published: March 16, 2023
Advance online publication: March 16, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Hiroki Watanabe, Akiyosh ...
Article type: LATE BREAKING CLINICAL TRIAL (JCS 2023)
Article ID: CJ-22-0837
Published: March 11, 2023
Advance online publication: March 11, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: There is a paucity of data on the effect of optimal intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) compared with standard PCI or coronary artery bypass grafting (CABG) in patients with multivessel disease.
Methods and Results: The OPTIVUS-Complex PCI study multivessel cohort was a prospective multicenter single-arm study enrolling 1,021 patients undergoing multivessel PCI including the left anterior descending coronary artery using IVUS aiming to meet the prespecified criteria for optimal stent expansion. We conducted propensity score matching analyses between the OPTIVUS group and historical PCI or CABG control groups from the CREDO-Kyoto registry cohort-3 (1,565 and 899 patients) fulfilling the inclusion criteria for this study. The primary endpoint was a composite of death, myocardial infarction, stroke, or any coronary revascularization. In the propensity score-matched cohort (OPTIVUS vs. historical PCI control: 926 patients in each group; OPTIVUS vs. historical CABG control: 436 patients in each group), the cumulative 1-year incidence of the primary endpoint was significantly lower in the OPTIVUS group than in the historical PCI control group (10.4% vs. 23.3%; log-rank P<0.001) or the historical CABG control group (11.8% vs. 16.5%; log-rank P=0.02).
Conclusions: IVUS-guided PCI targeting the OPTIVUS criteria combined with contemporary clinical practice was associated with superior clinical outcomes at 1 year compared with not only the historical PCI control, but also the historical CABG control.
View full abstract
-
Ayumu Fujioka, Kenji Yanishi, Arito Yukawa, Kojiro Imai, Isao Yokota, ...
Article type: LATE BREAKING CLINICAL TRIAL (JCS 2023)
Article ID: CJ-23-0046
Published: March 10, 2023
Advance online publication: March 10, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Thromboangiitis obliterans (TAO) can lead to the development of critical limb-threatening ischemia (CLTI). Despite conventional treatments, such as smoking cessation or revascularization, young patients (<50 years) still require limb amputation. Therapeutic angiogenesis using bone marrow-derived mononuclear cell (BM-MNC) implantation has been tested and shown to have reasonable efficacy in CLTI. In this multicenter prospective clinical trial, we evaluated the safety and efficacy of BM-MNC implantation in CLTI patients with TAO.
Methods and Results: We enrolled 22 CLTI patients with skin perfusion pressure (SPP) <30 mmHg. The primary endpoint of this trial is the recovery of SPP in the treated limb after a 180-day follow-up period. Secondary endpoints include the pain scale score and transcutaneous oxygen pressure (TcPO2). One patient dropped out during follow-up, leaving 21 patients (mean age 48 years, 90.5% male, Fontaine Class IV) for analysis. BM-MNC implantation caused no serious adverse events and increased SPP by 1.5-fold compared with baseline. Surprisingly, this effect was sustained over the longer term at 180 days. Secondary endpoints also supported the efficacy of this novel therapy in relieving pain and increasing TcPO2. Major amputation-free and overall survival probabilities at 3 years among all enrolled patients were high (95.5% and 89.5%, respectively).
Conclusions: BM-MNC implantation showed safety and significant efficacy in CLTI patients with TAO.
View full abstract
-
Yasuyoshi Takei, Hirofumi Tomiyama, Yukihito Higashi, Akira Yamashina, ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0810
Published: March 08, 2023
Advance online publication: March 08, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Endothelial dysfunction and increased left ventricular (LV) stiffness are associated with the incidence of heart failure with preserved ejection fraction (HFpEF). This study evaluated the association between endothelial dysfunction and LV diastolic stiffness.
Methods and Results: Endothelial dysfunction evaluated by flow-medicated vasodilation (FMD) and the reactive hyperemia index (RHI), which reflects endothelial dysfunction in the microvasculature, was measured in 112 subjects with hypertension in the Flow-Mediated Dilation Japan (FMD-J) study. Using transthoracic echocardiography, LV diastolic stiffness was evaluated by measuring diastolic wall strain (DWS) in the LV posterior wall. In this cross-sectional study, associations among FMD, RHI, and DWS were investigated using multiple regression analyses. The mean (±SD) age of the subjects 65±9 years, and 63% were men. DWS was significantly associated with RHI, but not FMD, on multivariate linear regression analysis (β=0.39; P<0.0001). This association was preserved in subjects without LV hypertrophy (β=0.46; P<0.0001). A DWS ≤median, suggesting increased LV diastolic stiffness, was significantly associated with RHI on multivariate logistic regression analysis (odds ratio 20.58; 95% confidence interval 4.83–87.63; P<0.0001). The receiver operating characteristic curve presented a cut-off value of 2.21 for RHI, with a sensitivity of 77% and a specificity of 71%, for DWS ≤median.
Conclusions: RHI, rather than FMD, was associated with DWS. Endothelial dysfunction in the microvasculature may be associated with increased LV diastolic stiffness.
View full abstract
-
Ramazan Duz, Salih Cibuk
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0750
Published: March 01, 2023
Advance online publication: March 01, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: This study examined whether the severity of mitral valve stenosis (MVS) is associated with oxidative stress (OS) markers in the blood, and other hematological and clinicodemographic parameters.
Methods and Results: This prospective study was conducted between March and May 2022. Seventy-five patients with newly diagnosed MVS (25 mild, 25 moderate, 25 severe) were included. Mild, moderate, and severe MVS was defined as MV area >2, 1.5–2, and <1.5 cm2, respectively. Various OS markers and laboratory parameters were determined in venous blood samples. For predictive analyses, 2 different analyses were performed to detect patients with severe MVS and those with moderate or severe (moderate/severe) MVS. Age (P=0.388) and sex (P=0.372) distribution were similar in the 3 groups. Multiple logistic regression analysis revealed that a high white blood cell (WBC) count (P=0.023) and high malondialdehyde (P=0.010), superoxide dismutase (SOD; P=0.008), and advanced oxidation protein products (AOPP; P=0.007) levels were independently associated with severe MVS. A low platelet count (P=0.030) and high malondialdehyde (P=0.018), SOD (P=0.008), and AOPP (P=0.001) levels were independently associated with having moderate/severe MVS. The best discriminatory factors for severe MVS were SOD (cut-off >315.5 ng/mL) and glutathione (cut-off >4.7 μmol/L).
Conclusions: MVS severity seems to be affected by oxidant markers (malondialdehyde and AOPP), antioxidant enzymes (SOD), and inflammation-related cells (WBC and platelets). Future studies are needed to examine these relationships in larger populations.
View full abstract
-
Shao-Wei Chen, Chia-Pin Lin, Yi-Hsin Chan, Victor Chien-Chia Wu, Yu-Ti ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0682
Published: February 21, 2023
Advance online publication: February 21, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Fluoroquinolone use can be associated with an increased risk of aortic aneurysm (AA) or aortic dissection (AD). The US Food and Drug Administration recently warned against fluoroquinolone use for high-risk patients, such as those with Marfan syndrome. However, the association between fluoroquinolone use and AA/AD risk was unknown in these high-risk patients and therefore it was studied in this work.
Methods and Results: Data were collected from a national database between 2000 and 2017 for 550 patients with AA/AD and any congenital aortic disease (mean age 41.5 years; 415 with Marfan syndrome). A case cross-over study was conducted to compare the risk of aortic events (AA/AD) associated with fluoroquinolone and amoxicillin use between the hazard period (from −60 days to −1 day) and a randomly selected reference period (−180 to −121 days; −240 to −181 days; and –300 to –241 days). Compared to the reference period without fluoroquinolone use, fluoroquinolone use during the hazard period was not associated with a greater risk of AA/AD (1.09% vs. 1.09%; odds ratio [OR] 1.000; 95% confidence interval [CI] 0.32–3.10), AA (OR 0.67; 95% CI 0.11–3.99), or AD (OR 1.33; 95% CI 0.30–5.96) in patients with congenital aortic disease or Marfan syndrome. This lack of association was maintained in subgroup analysis, including Marfan syndrome or not, age (≤50 vs. >50 years) and sex.
Conclusions: Fluoroquinolone use was not associated with an increased risk of AA/AD in patients with congenital aortic disease, including Marfan syndrome. More evidence is required for a fluoroquinolone pharmacovigilance plan in these patients.
View full abstract
-
Tetsuro Shimura, Masanori Yamamoto
Article type: EDITORIAL
Article ID: CJ-23-0034
Published: February 11, 2023
Advance online publication: February 11, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Marjolein C. de Jongh, Hikaru Tsuruta, Kentaro Hayashida, Hiromu Hase, ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0262
Published: February 09, 2023
Advance online publication: February 09, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: This study investigated the impact and predictive factors of concomitant significant tricuspid regurgitation (TR) and evaluated the roles of right ventricle (RV) function and the etiology of TR in the clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI).
Methods and Results: We assessed grading of TR severity, TR etiology, and RV function in pre- and post-TAVI transthoracic echocardiograms for 678 patients at Keio University School of Medicine. TR etiology was divided into 3 groups: primary TR, ventricular functional TR (FTR), and atrial FTR. The primary outcomes were all-cause and cardiovascular death. At baseline, moderate or greater TR was found in 55 (8%) patients and, after adjustment for comorbidities, was associated with increased all-cause death (hazard ratio [HR] 2.11; 95% confidence interval [CI] 1.19−3.77; P=0.011) and cardiovascular death (HR 2.29; 95% CI 1.06−4.99; P=0.036). RV dysfunction (RVD) also remained an independent predictor of cardiovascular death (HR 2.06; 95% CI 1.03−4.14; P=0.042). Among the TR etiology groups, patients with ventricular FTR had the lowest survival rate (P<0.001). Patients with persistent RVD after TAVI had a higher risk of cardiovascular death than those with a normal or recovered RV function (P<0.001).
Conclusions: The etiology of TR and RV function play an important role in predicting outcomes in concomitant TR patients undergoing TAVI.
View full abstract
-
Shintaro Minegishi
Article type: EDITORIAL
Article ID: CJ-22-0825
Published: January 27, 2023
Advance online publication: January 27, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Hidekazu Kondo, Naohiko Takahashi
Article type: EDITORIAL
Article ID: CJ-22-0823
Published: January 26, 2023
Advance online publication: January 26, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Shinichi Niwano
Article type: EDITORIAL
Article ID: CJ-22-0793
Published: January 21, 2023
Advance online publication: January 21, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0614
Published: January 17, 2023
Advance online publication: January 17, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Background: Previous studies on mortality in atrial fibrillation (AF) included a limited number of elderly patients receiving direct oral anticoagulants (DOACs). This subanalysis of the ANAFIE Registry evaluated 2-year mortality according to causes of death of elderly non-valvular AF (NVAF) patients in the DOAC era.
Methods and Results: The ANAFIE Registry was a multicenter prospective observational study. Mean patient age was 81.5 years and 57.3% of patients were male. Of the 32,275 patients completing the study, 2,242 died. The most frequent causes of death were cardiovascular (CV) death (32.4%), followed by infection (17.1%) and malignancy (16.1%). Incidence rates of CV-, malignancy-, and infection-related death were 1.20, 0.60, and 0.63 per 100 person-years, respectively. Patients aged ≥85 years showed increased proportions of non-CV and non-malignancy deaths and a decreased proportion of malignancy deaths compared with patients aged <85 years. The incidence of death due to congestive heart failure/cardiogenic shock, infection, and renal disease was higher in patients aged ≥85 than those aged <85 years. Compared with warfarin, DOACs were associated with a significantly lower risk of death by intracranial hemorrhage, ischemic stroke, and renal disease.
Conclusions: This subanalysis described the mortality according to causes of death of Japanese elderly NVAF patients in the DOAC era. Our results imply that a more holistic approach to comorbid conditions and stroke prevention are required in these patients.
View full abstract
-
Gary Tse, Sharen Lee, Tong Liu
Article type: EDITORIAL
Article ID: CJ-22-0792
Published: January 11, 2023
Advance online publication: January 11, 2023
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
-
Hideki Kitahara, Hiraku Kumamaru, Shun Kohsaka, Daichi Yamashita, Tomo ...
Article type: ORIGINAL ARTICLE
Article ID: CJ-22-0536
Published: December 27, 2022
Advance online publication: December 27, 2022
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
Supplementary material
Background: Limited data are available for clinical outcomes in patients who underwent urgent or emergency transcatheter aortic valve implantation (TAVI). This study investigated in-hospital and 1-year outcomes and explored prognostic covariates in urgent/emergency TAVI using nationwide registry data.
Methods and Results: Among 26,775 patients who underwent TAVI between August 2013 and December 2019, 25,495 with 1-year follow-up information were analyzed in this study. Baseline and procedural characteristics, as well as clinical adverse events, were compared between the urgent/emergency and elective TAVI groups. The primary outcome was all-cause mortality within 1 year after TAVI. Multivariable Cox regression models were constructed to identify independent predictors after urgent or emergency TAVI. Urgent or emergency TAVI was performed in 578 (2.3%) patients. The Society of Thoracic Surgeons score was significantly higher in the urgent/emergency than elective TAVI group (13.3% vs. 6.0%; P<0.001). Device success rate was comparable between the 2 groups. All-cause death-free survival within 1 year was lower in the urgent/emergency than elective TAVI group (77.2% vs. 92.2%; log rank P<0.001). Malignancy, albumin and creatinine concentrations, ejection fraction, and mean pressure gradient were associated with 1-year mortality in the urgent/emergency TAVI group.
Conclusions: Despite higher surgical risk and more comorbidities, the procedure was successfully performed in patients undergoing urgent/emergency TAVI, although it should be noted that prognosis was worse than for elective TAVI.
View full abstract
-
Yukihito Sato, Takashi Kuragaichi, Hiroyuki Nakayama, Kozo Hotta, Yuji ...
Article type: REVIEW
Article ID: CJ-22-0675
Published: December 23, 2022
Advance online publication: December 23, 2022
JOURNAL
OPEN ACCESS
FULL-TEXT HTML
ADVANCE PUBLICATION
The Japanese population is rapidly aging because of its long life expectancy and low birth rate; additionally, the number of patients with heart failure (HF) is increasing to the extent that HF is now considered a pandemic. According to a recent HF registry study, Japanese patients with HF have both medical and care-related problems. Although hospitalization is used to provide medical services, and institutionalization is used to provide care for frail older adults, it can be difficult to distinguish between them. In this context, multidisciplinary management of HF has become increasingly important in preventing hospital readmissions and maintaining a patient’s quality of life. Academia has promoted an increase in the number of certified HF nurses and educators. Researchers have issued numerous guidelines or statements on topics such as cardiac rehabilitation, nutrition, and palliative care, in addition to the diagnosis and treatment of acute and chronic HF. Moreover, the Japanese government has created incentives through various medical and long-term care systems adjustments to increase collaboration between these two fields. This review summarizes current epidemiological registries that focus not only on medical but also care-related problems and the 10 years of multidisciplinary management experience in Japanese medical and long-term care systems.
View full abstract